‘Black Widow’ Meets ‘Ballerina’ in New Action Epic Officially Taking Over Netflix Globally

Collider ·

An Indian action film from the sprawling "Spy Universe" franchise, starring Alia Bhatt as a genetically modified soldier seeking revenge, has become a surprise global hit on Netflix despite flopping at the cinema. The movie underperformed on its theatrical release on 3 July and drew poor reviews, but has found a much larger audience since streaming began at the end of August, landing on Netflix's domestic and global viewership charts. Its success highlights a growing trend of international, non-English-language films finding huge streaming audiences even after weak box-office runs.

The film sits within the same franchise as blockbusters Pathaan and War, though recent instalments Tiger 3 and War 2 had disappointed at the box office. Critics have noted its clear creative debt to Marvel's Black Widow and John Wick spin-off Ballerina, both in tone and premise. Its Netflix breakthrough follows similar recent global successes for the Spanish-language crime film Facing El Chapo and the Thai action film The Debt Collector, underlining Netflix's growing appetite for non-English hits.

In short

  • Indian action film flopped in cinemas but is thriving on Netflix
  • Alia Bhatt stars as a rogue genetically modified soldier
  • Part of a trend of international films becoming global Netflix hits

Explained simply

The film is part of India’s Spy Universe, a franchise that connects several action films, including the hits Pathaan and War. Alia Bhatt plays a genetically modified soldier seeking revenge, in a story that critics have compared with Black Widow and the John Wick spin-off Ballerina.

Its cinema release in July drew weak reviews and did not attract a large audience. Its later reach reflects how streaming can introduce films to viewers around the world, including audiences for films made in languages other than English.

Art Asia Business Culture Entertainment Markets TV World

Read the full article at the source →

Log in to join the discussion